SB-201993
SB-201993 is a selective leukotriene B₄ (LTB4) receptor antagonist with a Ki=7.6 nM for LTB4 receptors on human inflammatory cells. SB-201993 inhibits calcium mobilization in inflammatory cells and 5-lipoxygenase activity, exerting anti-inflammatory effects. SB-201993 is promising for research of inflammatory diseases (e.g., dermatitis, arthritis) [1].
Product Specifications
CAS Number
[150399-22-7]
UNSPSC
12352005
Target
Leukotriene Receptor
Related Pathways
GPCR/G Protein
Field of Research
Inflammation/Immunology
Smiles
O=C(O)C1=CC=CC(CSCC2=NC(/C=C/C(O)=O)=C(OCCCCCCCCC3=CC=C(OC)C=C3)C=C2)=C1
Molecular Formula
C32H37NO6S
Molecular Weight
563.70
References & Citations
[1]Sarau HM, et al. In vitro and in vivo pharmacological characterization of SB 201993, an eicosanoid-like LTB4 receptor antagonist with anti-inflammatory activity. Prostaglandins Leukot Essent Fatty Acids. 1999 Jul;61 (1) :55-64.
Shipping Conditions
Room temperature
Scientific Category
Reference compound1
Clinical Information
Phase 2
Isoform
LTB4
Curated Selection
Explore Other Products
Discover premium biology products from our extensive collection of 20M+ items
217405 10 mg
GSK-3beta Inhibitor XXVII, CESI (2- (3-chloro-4-hydroxyphenyl) -8- (1,1-dioxidoisothiazolidin-2-yl) -3-hydroxy-6-methyl-4H-chromen-4-one)
Ask
View Details 